Meyka Pro banner
cbdMD, Inc.

cbdMD, Inc. (YCBD) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

YCBDAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.58
$0.003(0.56%)
U.S. Market is Open · 13:56

cbdMD, Inc. (YCBD)

Meyka AI Score

Z

Key Financials

Market Cap6.3M
P/E Ratio-1.50
EPS (TTM)$-0.41
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$0.27
3 Months$0.59
1 Year Target$0.00

YCBD Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of cbdMD, Inc. (AMEX: YCBD) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, cbdMD, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of YCBD on the AMEX shows an RSI of 52.02, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.

Key metrics behind cbdMD, Inc.'s AMEX-traded stock include a P/E ratio of -1.50 and a market capitalization of 6.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of YCBD on the AMEX.

Price Performance (AMEX: YCBD)

1-Day Change
3.25%
5-Day Change
7.86%
1-Month Change
-23.28%
3-Month Change
-22.98%
6-Month Change
-11.82%
Year-to-Date (YTD) Change
-55.26%
1-Year Change
-36.04%
3-Year Change
-94.32%
5-Year Change
-99.92%
All-Time (Max) Change
-99.97%

Contact Information

704 445 3060
2101 Westinghouse Blvd, Charlotte, NC, 28217

Company Facts

420 Employees
IPO DateNov 17, 2017
CountryUS
Actively Trading

Frequently Asked Questions